SCHEMBL5167645

SCHEMBL5167645

OB(c1ccc(F)cc1)c1cccc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 5/20 0.59
ORAI1 Q96D31 4/20 0.59
ORAI2 Q96SN7 4/20 0.59
ORAI3 Q9BRQ5 4/20 0.59
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
PCSK9 Q8NBP7 1/20 0.41
GRIN2B Q13224 1/20 0.40
TSHR P16473 1/20 0.38
RAB9A P51151 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166569 0.87 MEN1 (0.45) TRPV6ORAI1ORAI2ORAI3MEN1
SCHEMBL1138514 0.86 ORAI1 (0.54) TRPV6ORAI1ORAI2ORAI3MEN1
SCHEMBL4827542 0.81 TRPV6 (0.62) TRPV6ORAI1ORAI2ORAI3MEN1
SCHEMBL4833078 0.80 TRPV6 (0.76) TRPV6ORAI1ORAI2ORAI3MEN1
SCHEMBL1003006 0.77 TRPV6 (1.00) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL11815 0.73 ENPP2 (0.56) TRPV6ORAI1ORAI2ORAI3ALDH1A1
SCHEMBL2399007 0.73 TRPV6 (0.52) TRPV6ORAI1ORAI2ORAI3PCSK9
SCHEMBL1187022 0.71 ORAI1 (0.40) TRPV6ORAI1ORAI2ORAI3MEN1
Boric Acid SCHEMBL2461539 0.71 MEN1 (0.52) MEN1KMT2AALDH1A1MAOAMAOB
SCHEMBL24871112 0.70 TSHR (0.44) TRPV6ORAI1ORAI2ORAI3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771182-A1 ANTI-PARASITIC USES OF BORINIC ACID COMPLEXES Anacor Pharmaceuticals, Inc. (US) 2007-04-11 EP disclosed
US-20060014723-A1 Anti-parasitic uses of borinic acid complexes ANACOR PHARMACEUTICALS, INC. 2006-01-19 US disclosed
WO-2005123095-A1 ANTI-PARASITIC USES OF BORINIC ACID COMPLEXES ANACOR PHARMACEUTICALS, INC. (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014723-A1 Anti-parasitic uses of borinic acid complexes BPGM, HRH1, HRH3 TRPV6 998/4885ORAI1 268/4885ORAI2 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.